Evidence map›Paper›PMID 22251616›Full record

ArticleBMC microbiology2012

Dominance of multidrug resistant CC271 clones in macrolide-resistant streptococcus pneumoniae in Arizona.

Jolene R Bowers, Elizabeth M Driebe, Jennifer L Nibecker, Bette R Wojack, Derek S Sarovich, Ada H Wong, Pius M Brzoska, Nathaniel Hubert, Andrew Knadler, Lindsey M Watson and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Molecular Epidemiology ofPathogens (Basel, Switzerland) · 2023
    Article
  5. Review
  6. Increase of Macrolide-Resistance inFrontiers in cellular and infection microbiology · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Macrolide Resistance inFrontiers in cellular and infection microbiology · 2016
    Review
  12. Mechanisms of genome evolution of Streptococcus.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2015
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Emergence of antibiotic-resistant extremophiles (AREs).Extremophiles : life under extreme conditions · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Jolene R BowersTranslational Genomics Research Institute, Flagstaff, AZ, USA. jbowers@tgen.org
Elizabeth M Driebe
Jennifer L Nibecker
Bette R Wojack
Derek S Sarovich
Ada H Wong
Pius M Brzoska
Nathaniel Hubert
Andrew Knadler
Lindsey M Watson
David M Wagner
Manohar R Furtado
Michael Saubolle
David M Engelthaler
Paul S Keim
Translational Genomics Research Institute · USNorthern Arizona University · USThermo Fisher Scientific (Norway) · NOUniversity of Arizona · US

Funding

Molecular Antibiotic Resistance Arrays for clinical microbiology laboratoriesR01AI090782 · NIAID · TRANSLATIONAL GENOMICS RESEARCH INST · PI KEIM, PAUL STEPHEN · 2010 to 2014
$4.6M
Real-Time PCR Assays for Direct Detection of Sepsis and CAP PathogensU01AI066581 · NIAID · TRANSLATIONAL GENOMICS RESEARCH INST · PI KEIM, PAUL STEPHEN · 2005 to 2009
$3.0M
NIAID NIH HHS 1R01AI090782-01NIAID NIH HHS U01AI066581
6 · The paper itself

Abstract

backgroundRates of resistance to macrolide antibiotics in Streptococcus pneumoniae are rising around the world due to the spread of mobile genetic elements harboring mef(E) and erm(B) genes and post-vaccine clonal expansion of strains that carry them.

resultsCharacterization of 592 clinical isolates collected in Arizona over a 10 year period shows 23.6% are macrolide resistant. The largest portion of the macrolide-resistant population, 52%, is dual mef(E)/erm(B)-positive. All dual-positive isolates are multidrug-resistant clonal lineages of Taiwan19F-14, mostly multilocus sequence type 320, carrying the recently described transposon Tn2010. The remainder of the macrolide resistant S. pneumoniae collection includes 31% mef(E)-positive, and 9% erm(B)-positive strains.

conclusionsThe dual-positive, multidrug-resistant S. pneumoniae clones have likely expanded by switching to non-vaccine serotypes after the heptavalent pneumococcal conjugate vaccine release, and their success limits therapy options. This upsurge could have a considerable clinical impact in Arizona.

Indexed as

Drug Resistance, Multiple, BacterialAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsArizonaChildChild, PreschoolCluster AnalysisDNA Transposable ElementsFemaleGenes, BacterialGenotypeHumansInfantAnti-Bacterial AgentsDNA Transposable ElementsMacrolides

Identifiers

PMID22251616
PMCPMC3285076
OpenAlexW2095173032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.